Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

✍ Scribed by Brass, Eric P.; Anthony, Richard; Dormandy, John; Hiatt, William R.; Jiao, Jenny; Nakanishi, Atsushi; McNamara, Thomas; Nehler, Mark

• Book ID: 123174217
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 264 KB
• Volume: 43
• Category: Article
• ISSN: 1097-6809
• DOI: 10.1016/j.jvs.2005.11.041